Xiamen Kingdomway Group Soars 10.03%, Hits Intraday High of CNY 16.46

Xiamen Kingdomway Group Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance, gaining 10.03% on August 10, 2026. The stock reached an intraday high of CNY 16.46, marking a notable achievement in a day where the broader China Shanghai Composite index rose by only 0.67%. Over the past week, Xiamen Kingdomway has shown a robust performance with a 15.02% increase, significantly outpacing the 4.12% rise of the Shanghai Composite. In the last month, the stock has surged by 20.23%, while the composite index has faced a slight decline of 0.74%. However, the company has faced challenges over the longer term, with a 14.27% decrease in stock value over the past year and a 53.83% drop over the last five years. Key financial metrics indicate a market capitalization of CNY 10,038 million, a P/E ratio of 25.00, and a dividend yield of 2.43%. Despite recent gains, the company has reported negative results in its last two quarters, highlighting ongoing financial pressures.